Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018276

Expand all

XANAX (ALPRAZOLAM)
0.25MG
Marketing Status: Prescription

Active Ingredient: ALPRAZOLAM
Proprietary Name: XANAX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018276
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

XANAX (ALPRAZOLAM)
0.5MG
Marketing Status: Prescription

Active Ingredient: ALPRAZOLAM
Proprietary Name: XANAX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018276
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

XANAX (ALPRAZOLAM)
1MG
Marketing Status: Prescription

Active Ingredient: ALPRAZOLAM
Proprietary Name: XANAX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018276
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

XANAX (ALPRAZOLAM)
2MG
Marketing Status: Prescription

Active Ingredient: ALPRAZOLAM
Proprietary Name: XANAX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N018276
Product Number: 004
Approval Date: Nov 27, 1985
Applicant Holder Full Name: UPJOHN US 2 LLC
Marketing Status:  Prescription
Patent and Exclusivity Information